Search - tctmd.com

Displaying 101 - 120 of 210

Sort: Relevancy | Date

Presentation TCT 2015

TCT 12: Impact of Overlap on Long-term Clinical Outcomes in Patients Undergoing Everolimus-Eluting Bioresorbable Vascular Scaffolds Implantation in Routine Clinical Practice Insights From the European Multicenter GHOST-EU Registry

Presenter: Stephen G. Ellis, Lorenz Raber, Luis Ortega-Paz

October 13, 2015

Presentation TCT 2015

TCT 11: Five-year Follow-up of the First-in-Man Use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: A Serial Multi-Imaging Modality Study

Presenter: Stephen G. Ellis, Lorenz Raber, Patrick W. Serruys

October 13, 2015

Presentation TCT 2015

What Have We Learned From All-Comers Head-to-Head DES Trials II? The COMPARE Trials

Presenter: Stephen G. Ellis, John A. Ormiston, Pieter C. Smits

October 11, 2015

Presentation TCT 2015

What Have We Learned From All-Comers Head-to-Head DES Trials I? The SORT OUT Trial

Presenter: Stephen G. Ellis, John A. Ormiston, Evald H. Christiansen

October 11, 2015

Presentation TCT 2015

Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update

Presenter: Stephen G. Ellis, John A. Ormiston, Dean J. Kereiakes

October 11, 2015

Presentation TCT 2015

Update on Biolimus-Eluting Stent Platforms: BioMatrix and Nobori Program Update

Presenter: Stephen G. Ellis, John A. Ormiston, Philip M. Urban

October 11, 2015

Presentation TCT 2015

Durable-Polymer DES 5-Year Outcomes: RESOLUTE Update

Presenter: Stephen G. Ellis, John A. Ormiston, Sigmund Silber

October 11, 2015

Presentation TCT 2015

Durable-Polymer DES 5-Year Outcomes: XIENCE/PROMUS and PROMUS Element Update

Presenter: Stephen G. Ellis, John A. Ormiston, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? No, This Theoretical Goal Does Not Hold Up Under Scrutiny!

Presenter: Stephen G. Ellis, John A. Ormiston, Tullio Palmerini

October 11, 2015

Presentation TCT 2015

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal!

Presenter: Stephen G. Ellis, John A. Ormiston, Robert A. Byrne

October 11, 2015

Presentation TCT 2015

Clinical Outcomes of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Presenter: Stephen G. Ellis, John A. Ormiston, Sripal Bangalore

October 11, 2015

Presentation TCT 2015

Design of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Presenter: Stephen G. Ellis, John A. Ormiston

October 11, 2015

News Daily News

伴随着新一代 DES 投入应用，超长支架与不良事件有关

Nicole Lou

June 16, 2015

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Daily News

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Nicole Lou

June 16, 2015

News Daily News

积极准备下钙化灶 BRS 置入可行

April 29, 2015

News Daily News

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

April 29, 2015

Advertisement

TCT 12: Impact of Overlap on Long-term Clinical Outcomes in Patients Undergoing Everolimus-Eluting Bioresorbable Vascular Scaffolds Implantation in Routine Clinical Practice Insights From the European Multicenter GHOST-EU Registry

TCT 11: Five-year Follow-up of the First-in-Man Use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: A Serial Multi-Imaging Modality Study

What Have We Learned From All-Comers Head-to-Head DES Trials II? The COMPARE Trials

What Have We Learned From All-Comers Head-to-Head DES Trials I? The SORT OUT Trial

Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update

Update on Biolimus-Eluting Stent Platforms: BioMatrix and Nobori Program Update

Durable-Polymer DES 5-Year Outcomes: RESOLUTE Update

Durable-Polymer DES 5-Year Outcomes: XIENCE/PROMUS and PROMUS Element Update

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? No, This Theoretical Goal Does Not Hold Up Under Scrutiny!

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal!

Clinical Outcomes of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Design of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

伴随着新一代 DES 投入应用，超长支架与不良事件有关

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

积极准备下钙化灶 BRS 置入可行

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content